David A. Hendricks

635 total citations
16 papers, 488 citations indexed

About

David A. Hendricks is a scholar working on Epidemiology, Infectious Diseases and Hepatology. According to data from OpenAlex, David A. Hendricks has authored 16 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Infectious Diseases and 8 papers in Hepatology. Recurrent topics in David A. Hendricks's work include Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (8 papers) and Viral gastroenteritis research and epidemiology (4 papers). David A. Hendricks is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Hepatitis C virus research (8 papers) and Viral gastroenteritis research and epidemiology (4 papers). David A. Hendricks collaborates with scholars based in United States, Germany and Canada. David A. Hendricks's co-authors include Jean L. Patterson, Kenneth McIntosh, Lorraine Comanor, B Hoo, Janice A. Kolberg, Bruce Irvine, Paul Neuwald, Robert P. Perrillo, Mickey S. Urdea and Christoph Sarrazin and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

David A. Hendricks

15 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Hendricks United States 10 417 253 127 56 45 16 488
Alessandra Zappá Italy 15 400 1.0× 127 0.5× 113 0.9× 30 0.5× 30 0.7× 23 452
Ming Chang United States 12 214 0.5× 208 0.8× 191 1.5× 21 0.4× 83 1.8× 30 585
Alfredo P. Martínez Argentina 13 231 0.6× 137 0.5× 178 1.4× 32 0.6× 42 0.9× 31 353
Véronique Brodard France 12 253 0.6× 98 0.4× 170 1.3× 35 0.6× 18 0.4× 25 485
Pierre Berthelot France 9 272 0.7× 250 1.0× 60 0.5× 25 0.4× 20 0.4× 10 447
J Slusarczyk Poland 14 444 1.1× 285 1.1× 90 0.7× 12 0.2× 38 0.8× 71 622
Lize Cuypers Belgium 14 296 0.7× 168 0.7× 297 2.3× 29 0.5× 62 1.4× 59 556
David Bibby United Kingdom 16 254 0.6× 58 0.2× 236 1.9× 39 0.7× 90 2.0× 23 482
M. Duhamel Belgium 6 532 1.3× 574 2.3× 102 0.8× 7 0.1× 72 1.6× 8 743
Luna Colagrossi Italy 11 197 0.5× 112 0.4× 145 1.1× 22 0.4× 24 0.5× 35 331

Countries citing papers authored by David A. Hendricks

Since Specialization
Citations

This map shows the geographic impact of David A. Hendricks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Hendricks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Hendricks more than expected).

Fields of papers citing papers by David A. Hendricks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Hendricks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Hendricks. The network helps show where David A. Hendricks may publish in the future.

Co-authorship network of co-authors of David A. Hendricks

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Hendricks. A scholar is included among the top collaborators of David A. Hendricks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Hendricks. David A. Hendricks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lichtenstein, Gary R., Heidi C. Waters, Susan McDonald, et al.. (2010). Assessing Drug Treatment Preferences of Patients with Crohnʼs Disease. Patient. 3(2). 113–123. 16 indexed citations
2.
O’Neill, Simon, et al.. (2007). 406: Clinical practice review. Biology of Blood and Marrow Transplantation. 13(2). 146–146. 1 indexed citations
3.
Martinot-Peignoux, Michelle, Lorraine Comanor, James M. Minor, et al.. (2006). Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C. Journal of Viral Hepatitis. 13(10). 701–707. 12 indexed citations
4.
Krajden, Mel, Annie Mak, Gail McNabb, et al.. (2004). Evaluation of the Core Antigen Assay as a Second-Line Supplemental Test for Diagnosis of Active Hepatitis C Virus Infection. Journal of Clinical Microbiology. 42(9). 4054–4059. 22 indexed citations
5.
Martinot‐Peignoux, Michèle, Lorraine Comanor, Corinne Castelnau, et al.. (2003). Early virologic response (EVR) at week 8 is more predictive of sustained response (SR) to pegylated combination therapy than at week 12. Journal of Hepatology. 38. 154–155. 1 indexed citations
6.
Comanor, Lorraine & David A. Hendricks. (2003). Hepatitis C virus RNA tests: performance attributes and their impact on clinical utility. Expert Review of Molecular Diagnostics. 3(6). 689–702. 1 indexed citations
7.
Hendricks, David A., et al.. (2003). Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA. Journal of Clinical Microbiology. 41(2). 651–656. 35 indexed citations
8.
9.
Comanor, Lorraine, Frank Anderson, Marc G. Ghany, et al.. (2001). Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment. The American Journal of Gastroenterology. 96(10). 2968–2972. 55 indexed citations
10.
Sarrazin, Christoph, David A. Hendricks, Farhad Sedarati, & Stefan Zeuzem. (2001). Assessment, by Transcription-Mediated Amplification, of Virologic Response in Patients with Chronic Hepatitis C Virus Treated with Peginterferon α-2a. Journal of Clinical Microbiology. 39(8). 2850–2855. 37 indexed citations
11.
Hendricks, David A., B Hoo, Janice A. Kolberg, et al.. (1995). Quantitation of HBV DNA in Human Serum Using a Branched DNA (bDNA) Signal Amplification Assay. American Journal of Clinical Pathology. 104(5). 537–546. 108 indexed citations
12.
Hendricks, David A., et al.. (1988). Biochemical and Biophysical Characteristics of Rio Bravo Virus (Flaviviridae). Journal of General Virology. 69(2). 337–347. 4 indexed citations
13.
Hendricks, David A., et al.. (1988). Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. Virus Research. 11. 15–15. 2 indexed citations
14.
Hendricks, David A., Kenneth McIntosh, & Jean L. Patterson. (1988). Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. Journal of Virology. 62(7). 2228–2233. 72 indexed citations
15.
Hendricks, David A., et al.. (1987). Appearance of a Soluble Form of the G Protein of Respiratory Syncytial Virus in Fluids of Infected Cells. Journal of General Virology. 68(6). 1705–1714. 77 indexed citations
16.
Hendricks, David A., James L. Hardy, & William C. Reeves. (1983). Comparison of Biological Properties of St. Louis Encephalitis and Rio Bravo Viruses. American Journal of Tropical Medicine and Hygiene. 32(3). 602–609. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Zappá Breakdown of academic impact, for papers by Ming Chang Breakdown of academic impact, for papers by Alfredo P. Martínez Breakdown of academic impact, for papers by Véronique Brodard Breakdown of academic impact, for papers by Pierre Berthelot Breakdown of academic impact, for papers by J Slusarczyk Breakdown of academic impact, for papers by Lize Cuypers Breakdown of academic impact, for papers by David Bibby Breakdown of academic impact, for papers by M. Duhamel Breakdown of academic impact, for papers by Luna Colagrossi
Rankless by CCL
2026